HLB Life Science KRX:067630KOSDAQ

HLB생명과학 · Korean news coverage and regulatory filings, organized.

Articles, 24h0
Articles, 7 days1
DART filings, 7 days2
Articles tracked9since Sep 11

In Q3 2026, HLB Life Science reported revenue of ₩15.2bn, up 11.7% year on year, and an operating loss of ₩4.9bn. HLB Life Science (HLB생명과학) appeared in 1 Korean news article and 2 DART filings over the past seven days. Coverage peaked on Nov 4 with 1 article. It was most often mentioned alongside HLB.

Filing signals 4 quarters of losses Screener

HLB Life Science today: up or down?

No sign-up, one tap a day. These numbers show what visitors think and are not investment advice.

Upcoming dates as filed

  • Mar 31 Annual report filing deadlinein 134 days · period ending Dec 2026

Dates HLB Life Science stated in its DART filings. A conversion period opening does not mean new shares appear that day; bondholders must request conversion.

HLB Life Science quarterly results consolidated, KRW

QuarterRevenueYoYOperating profitNet income
Q3 2026₩15.2bn+11.7%−₩4.9bn
margin −32.2%
−₩26.5bn
Q2 2026₩14.7bn+24.5%−₩7.6bn
margin −51.6%
−₩8.7bn
Q1 2026₩15.2bn-44.7%−₩6.5bn
margin −42.5%
−₩7.8bn
Q4 2025 derived₩10.9bn-61.8%−₩5.8bn
margin −53.0%
₩20.1bn
Q3 2025₩13.6bn-47.9%−₩3.8bn
margin −28.2%
−₩36.8bn
Q2 2025₩11.8bn+57.4%−₩6.7bn
margin −56.5%
−₩26.1bn
Q1 2025₩27.5bn+15.0%−₩5.9bn
margin −21.6%
−₩57.2bn
Q4 2024 derived₩28.7bn+21.8%−₩6.8bn
margin −23.9%
−₩58.6bn

HLB Life Science ranks #2198 of 2,345 Korean listed companies by Q3 2026 operating profit. Q3 2026 Korean earnings rankings →

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

HLB Life Science top stories 2 weeks, by number of outlets

  1. 1
    HLB Bioscience expands Canadian exports and Chinese syringe imports on both fronts
    1 outlets · 1 articlesFirst report Nov 13 10:20 메디코파마
  2. 2

Latest HLB Life Science news Korean headlines